placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in guatemala. | sixty-six guatemalans with parasitologically proven cutaneous leishmaniasis were randomly and equally divided into 3 treatment groups: those receiving meglumine antimonate (glucantime), 850 mg antimony/day im for 15 days; those receiving localized controlled heat from a radio-frequency generator, 50 degrees c for 30 sec, 3 treatments at 7 day intervals; and those receiving treatment with a placebo. of 53 isolates identified, 40 were leishmania braziliensis braziliensis and 13 were l. mexicana me ... | 1990 | 2405727 |